Category | THCA | THC |
Psychoactivity | Non-psychoactive; does not produce a high | Psychoactive; responsible for the euphoric effects |
Origin | Found in live, raw cannabis plants; derived from CBGa | Created through decarboxylation (heating) of THCA |
Chemical Structure | Contains a carboxyl group that is removed to form THC | Has no carboxyl group; fully decarboxylated form |
Consumption Methods | Typically consumed in raw, unheated forms (juicing, tinctures) | Commonly consumed through smoking, vaporization, oils, edibles |
Effects | Minimal to no noticeable effects; slight energy or drowsiness reported; may provide health benefits without psychoactive effects | Produces euphoria, relaxation, altered perception, increased appetite, and possible anxiety |
Potential Medical Benefits | Being researched for anti-inflammatory, neuroprotective, and anti-nausea properties; may be beneficial for arthritis and neurodegenerative diseases | Known for pain relief, appetite stimulation, mood enhancement, and management of symptoms related to various medical conditions |
Side Effects | Few known side effects; limited research available; anecdotal reports include slight drowsiness | May cause anxiety, dry mouth, memory loss, increased heart rate, and red eyes |
Legal Status | Legal in the U.S. under the 2018 Farm Bill if derived from hemp and contains less than 0.3% THC | Federally illegal in the U.S., but legal in certain states for medical or recreational use |
Conversion Process | Must be decarboxylated to convert into THC | Directly active form of THCA; no conversion needed |
Research Status | Ongoing studies for potential therapeutic effects | Extensive research supports various medical uses |